Black Rock Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,568,654 shares of REGN stock, worth $8.4 Billion. This represents 0.19% of its overall portfolio holdings.
Number of Shares
8,568,654
Previous 8,629,707
0.71%
Holding current value
$8.4 Billion
Previous $7.58 Billion
8.81%
% of portfolio
0.19%
Previous 0.2%
Shares
12 transactions
Others Institutions Holding REGN
# of Institutions
1,426Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$8.75 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$7.57 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.75 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.56 Billion0.76% of portfolio
-
Capital International Investors Los Angeles, CA3.13MShares$3.07 Billion0.62% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $105B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...